Ryoichi Ishibashi

724 citations
28 papers · 237 indexed · h-index 9
Topics
Diabetes Treatment and Management (12 papers)Retinal Diseases and Treatments (6 papers)Metabolism, Diabetes, and Cancer (4 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsEMBO Reports
Partner nations
JapanSwedenSingapore

In The Last Decade

Ryoichi Ishibashi

25 papers receiving 230 citations

Peers

Ryoichi Ishibashi
Comparison fields: 5 of 65
  • Endocrinology, Diabetes and Metabolism 83
  • Molecular Biology 78
  • Surgery 53
  • Nephrology 39
  • Ophthalmology 34
Replace Xinyang Yu with:
Xinyang Yu China
Xiaojing Ma China
Ines Cilenšek Slovenia
Maikki Parkkonen Finland
Maximilian Kopp Germany
Irene Fornaciari Italy
Robert Höpfner Canada
Yoshie Arai Japan
Steve T. Yeh United States
Tzu-Yuan Wang Taiwan
Ryoichi Ishibashi relative to Xinyang Yu China Xinyang Yu's profile →
Citations per field
00.5×1.6×
Xinyang Yu · 1×
Citations per year

Countries citing papers authored by Ryoichi Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Ryoichi Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoichi Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoichi Ishibashi more than expected).

Fields of papers citing papers by Ryoichi Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoichi Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoichi Ishibashi. The network helps show where Ryoichi Ishibashi may publish in the future.

Co-authorship network of co-authors of Ryoichi Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoichi Ishibashi. A scholar is included among the top collaborators of Ryoichi Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoichi Ishibashi. Ryoichi Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 6
5 3
6 6
7 3
8 14
9 1
10 6
11 11
12 6
13 5
14 20
15 15
16 8
17 7
18 15
19 20
20 37

About Ryoichi Ishibashi

Ryoichi Ishibashi is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology and Nephrology, having authored 28 papers that have together received 237 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Retinal Diseases and Treatments (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Nephrology (39 citations), Endocrinology, Diabetes and Metabolism (83 citations) and Ophthalmology (34 citations). Ryoichi Ishibashi has collaborated with scholars based in Japan, Sweden and Singapore. Frequent co-authors include Koutaro Yokote, Minoru Takemoto, Takahiro Ishikawa, Masaya Koshizaka, Kazuki Kobayashi, Yoshiro Maezawa, Shunichiro Onishi, Peng He, Emiko Okabe and Tomoaki Tatsumi. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and EMBO Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026